This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Reports
Country profiles
Clinical Excellence
Cardiology
Respiratory
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Oncology
5-alpha reductase inhibitor use not linked to prostate cancer mortality
Read more
Both forms of cardiovascular disease associated with higher cancer risk
Read more
Pembrolizumab explored in the treatment of advanced biliary tract cancer
Read more
Psilocybin therapy effective for major depression among cancer patients
Read more
GD2-CART01 effective for R/R high-risk neuroblastoma
Read more
Neoadjuvant socazolimab shows promise for locally advanced oesophageal squamous cell cancer
Read more
Ide-cel provides 51% reduction in the risk of progression or death in R/R multiple myeloma
Read more
Aggressive end-of-life care more common in nursing home compared to community residents
Read more
Prostate cancer mortality no different in trial of three treatment interventions
Read more
DNA damage to oral cells similar in never smoking vapers and current smokers
Read more
Neoadjuvant pembrolizumab superior to adjuvant therapy in advanced resectable melanoma
Read more
Rucaparib offers survival advantage over usual care in metastatic prostate cancer
Read more
Poor cardiovascular risk control identified in half of men with prostate cancer
Read more
Pembrolizumab shows benefit in high-risk BCG non-responsive bladder cancer
Read more
T-VEC virotherapy and NAC improves response in triple negative breast cancer
Read more
Darolutamide improves overall survival in metastatic hormone sensitive prostate cancer
Read more
Neoadjuvant nivolumab provides significant 5-year overall survival in lung cancer
Read more
Page 5 of 38
« First
«
...
3
4
5
6
7
...
10
20
30
...
»
Last »
Popular articles
Low-carbon salbutamol inhaler a step closer as phase three trials announced
23 November, 2023
Consultant pay reform package agreed in principle with UK Government
27 November, 2023
HPV vaccine has changed strains in circulation ‘impacting screening plans’, Finnish study shows
24 November, 2023
×
Search for: